| Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|
 Filter
|
Jianjun Chen
|
Prior to Jul 01, 2020 |
||||||
| GSE116548 |
RNA-seq in murine acute myeloid leukemia (AML) cells with and without knockdown of Tet1
|
6 | Jianjun Chen | Jun 30, 2020 | ||||
| GSE116549 |
5hmC-seq in human MonoMac6 acute myeloid leukemia (AML) cells with and without knockdown of TET1
|
3 | Jianjun Chen | Jun 30, 2020 | ||||
| GSE116551 |
RNA-seq and 5hmC-seq in acute myeloid leukemia (AML) cells with and without knockdown of Tet1
|
9 | Jianjun Chen | Jun 30, 2020 | ||||
| GSE134763 |
Sequencing of mRNA with N6-methyladenosine (m6A) modification in AML cells upon ALKBH5 knockdown or overexpression
|
4 | Jianjun Chen | May 26, 2020 | ||||
| GSE144959 |
Sequencing of mRNA in AML cells upon ALKBH5 knockdown and actinomycin D treatment for different time
|
12 | Jianjun Chen | May 26, 2020 | ||||
| GSE144963 |
Sequencing of RNA fragments immunoprecipitated by anti-Flag in ALKBH5 overexpression NOMO1 cells
|
4 | Jianjun Chen | May 26, 2020 | ||||
| GSE144968 |
Sequencing of mRNA in AML cells upon ALKBH5 knockdown
|
8 | Jianjun Chen | May 26, 2020 | ||||
| GSE144984 |
ALKBH5 regulates AML development and LSC as an m6A eraser
|
28 | Jianjun Chen | May 26, 2020 | ||||
| GSE136204 |
Effective FTO inhibitors with potent anti-tumor efficacy suppress cancer stem/initiating cell self-renewal and overcome immune evasion
|
16 | Jianjun Chen | Apr 11, 2020 | ||||
| GSE145363 |
Targeting FTO suppresses cancer stem cell maintance and immune evasion
|
4 | Jianjun Chen | Apr 11, 2020 | ||||
| GSE103143 |
The mechanism of HHT in treating acute myeloid leukemia on RNA level.
|
6 | Jianjun Chen | Dec 19, 2019 | ||||
| GSE103144 |
Genome wide browser of 5hmc abundance in MA9.3ITD cell with PBS or HHT treatment.
|
2 | Jianjun Chen | Dec 19, 2019 | ||||
| GSE103497 |
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition
|
16 | Jianjun Chen | May 04, 2019 | ||||
| GSE103494 |
RNA seq with AML cells (NB4) upon FTO knockdown
|
4 | Jianjun Chen | Apr 29, 2019 | ||||
| GSE103495 |
RNA seq with AML (NB4) cells upon FTO inhibition
|
9 | Jianjun Chen | Apr 29, 2019 | ||||
| GSE103496 |
Sequencing of mRNA with N6-methyladenosine (m6A) modification in AML cells upon DMSO or FTO inhibitor treatment
|
3 | Jianjun Chen | Apr 29, 2019 | ||||
| GSE110318 |
Profiling of Histone H3 Trimethylation at Lysine 36 (H3K36me3) in HepG2 cells: SETD2 knockdown and control cells
|
8 | Jianjun Chen | Feb 21, 2019 | ||||
| GSE110320 |
Profiling of N6-methyladenosine in HepG2 cells: SETD2, METTL3, METTL14 or WTAP knockdown and control cells
|
42 | Jianjun Chen | Feb 21, 2019 | ||||
| GSE110321 |
Profiling of Histone H3 Trimethylation at Lysine 36 (H3K36me3) in mouse embryonic stem cells: Setd2 knockdown and control cells
|
8 | Jianjun Chen | Feb 21, 2019 | ||||
| GSE110322 |
Profiling of N6-methyladenosine in mouse embryonic stem cells: Setd2 knockdown and control cells
|
8 | Jianjun Chen | Feb 21, 2019 |
